LEXARIA BIOSCIENCE CORP (LEXX) Forecast, Price Target & Analyst Ratings

NASDAQ:LEXXUS52886N4060

Current stock price

0.7504 USD
-0.02 (-3.15%)
At close:
0.778 USD
+0.03 (+3.68%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for LEXARIA BIOSCIENCE CORP (LEXX).

Forecast Snapshot

Consensus Price Target

Price Target
$4.59
+ 511.67% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
Apr 13, 2026
Period
Q2 / 2026
EPS Estimate
-$0.10
Revenue Estimate
51K

ChartMill Buy Consensus

Rating
82.86%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$4.59
Upside
+ 511.67%
From current price of $0.75 to mean target of $4.59, Based on 7 analyst forecasts
Low
$1.52
Median
$6.12
High
$6.30

Price Target Revisions

1 Month
0.00%
3 Months
-15.62%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for LEXX. The average price target is 4.59 USD. This implies a price increase of 511.67% is expected in the next year compared to the current price of 0.7504.
The average price target has been revised downward by 15.62% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

LEXX Current Analyst RatingLEXX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

LEXX Historical Analyst RatingsLEXX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.86%
LEXX was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about LEXX.
In the previous month the buy percentage consensus was at a similar level.
LEXX was analyzed by 7 analysts. More opinions would make the average more meaningful.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-26HC Wainwright & Co.Maintains Buy -> Buy
2025-07-29HC Wainwright & Co.Maintains Buy -> Buy
2025-07-01HC Wainwright & Co.Maintains Buy -> Buy
2025-01-24HC Wainwright & Co.Maintains Buy -> Buy
2024-12-02HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-25HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-18HC Wainwright & Co.Reiterate Buy -> Buy
2024-07-10HC Wainwright & Co.Initiate Buy
2024-03-05Maxim GroupMaintains Buy -> Buy
2023-07-21Maxim GroupInitiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Apr 13, 2026
Period
Q2 / 2026
EPS Estimate
-$0.10
Revenue Estimate
51K
Revenue Q2Q
-70.69%
EPS Q2Q
35.40%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
-50.00%
EPS (1 Month)
0.00%
EPS (3 Months)
36.67%

Next Earnings Summary

LEXX is expected to report earnings on 4/13/2026. The consensus EPS estimate for the next earnings is -0.1 USD and the consensus revenue estimate is 51.00K USD.
The next earnings revenue estimate has been revised downward by 50% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

Full Analyst Estimates 2026 - 2032

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028 2029 2030 2031 2032
Revenue
YoY % growth
LEXX revenue by date.LEXX revenue by date.
230K
-11.54%
464.3K
101.87%
705.9K
52.04%
204K
-71.10%
1.431M
601.47%
1.617M
13.00%
71.59M
4,327.33%
138.99M
94.15%
184.25M
32.56%
231.35M
25.56%
EBITDA
YoY % growth
LEXX ebitda by date.LEXX ebitda by date.
-6.38M
12.36%
-5.677M
11.02%
-11.793M
-107.73%
N/AN/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
LEXX ebit by date.LEXX ebit by date.
-6.53M
11.52%
-5.753M
11.90%
-11.881M
-106.51%
-9.187M
22.67%
-9.126M
0.67%
-9.501M
-4.11%
32.809M
445.31%
93.056M
183.63%
136.01M
46.16%
180.71M
32.87%
Operating Margin
LEXX operating margin by date.LEXX operating margin by date.
-2,839.13%-1,239.09%-1,683.06%-4,503.50%-637.73%-587.59%45.83%66.95%73.82%78.11%
EPS
YoY % growth
LEXX eps by date.LEXX eps by date.
N/A
-15.79%
-0.46
59.00%
-0.65
-41.30%
-0.37
43.51%
-0.32
13.89%
-0.29
9.68%
N/AN/AN/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.10
35.40%
-0.09
58.71%
-0.11
13.69%
-0.30
-322.57%
-0.29
-194.74%
-0.31
-252.94%
-0.32
-181.82%
Revenue
Q2Q % growth
51K
-70.69%
51K
-70.69%
102K
-41.38%
N/AN/AN/AN/A
EBITDA
Q2Q % growth
N/AN/AN/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-2.234M
18.80%
-2.31M
38.40%
-3.162M
-17.61%
-5.871M
-273.10%
-6.127M
-174.29%
-6.637M
-187.28%
-6.892M
-117.97%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

LEXX Yearly Revenue VS EstimatesLEXX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
LEXX Yearly EPS VS EstimatesLEXX Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2021 2022 2023 2024 2025 2026 2027 2028 -0.2 -0.4 -0.6 -0.8 -1

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
15.99%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
33.32%
Revenue Next 5 Year
189.60%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A

LEXARIA BIOSCIENCE CORP / LEXX Forecast FAQ

Can you provide the average price target for LEXARIA BIOSCIENCE CORP stock?

7 analysts have analysed LEXX and the average price target is 4.59 USD. This implies a price increase of 511.67% is expected in the next year compared to the current price of 0.7504.

What is the next earnings date for LEXX stock?

LEXARIA BIOSCIENCE CORP (LEXX) will report earnings on 2026-04-13.

What are the consensus estimates for LEXX stock next earnings?

The consensus EPS estimate for the next earnings of LEXARIA BIOSCIENCE CORP (LEXX) is -0.1 USD and the consensus revenue estimate is 51.00K USD.

How many analysts cover LEXARIA BIOSCIENCE CORP (LEXX) stock?

The number of analysts covering LEXARIA BIOSCIENCE CORP (LEXX) is 7.